| Product Name | NebuSelect™ Recombinant Human IGFBP2, His-tag |
|---|---|
| Catalog Number | NBL-242525 |
| Alias/Synonyms | IGFBP2; IBP-2; IGFBP-2; BP2; AI255832; mIGFBP-2; IGFBP2; IGF-BP53 |
| Appearance | see COA |
| Molecule Weight | Ala36-Gln325 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P18065 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242525-100ug | 100ug | Inquire | Inquire | |
| NBL-242525-1mg | 1mg | Inquire | Inquire | |
| NBL-242525-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IGFBP2, His-tag
Catalog#:
NBL-242525
Description:
NebuSelect™ Recombinant Human IGFBP2, His-tag(Cat#NBL-242525) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala36-Gln325.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.5 kDa. Due to glycosylation, the protein migrates to 33-40 kDa based on Bis-Tris PAGE result.
Target Name:
IGFBP2; IBP-2; IGFBP-2; BP2; AI255832; mIGFBP-2; IGFBP2; IGF-BP53
Target Information:
Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) was discovered and identified as an IGF system regulator, controlling the distribution, function, and activity of IGFs in the pericellular space. IGFBP2 is a developmentally regulated gene that is highly expressed in embryonic and fetal tissues and markedly decreases after birth. Aberrant expression of IGFBP2 in cancer acts as a hub of an oncogenic network, integrating multiple cancer signaling pathways and serving as a potential therapeutic target for cancer treatment.
Amino Acid Sequence:
Ala36-Gln325
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.